References

  1. Di Lorenzo G. Update on classic Kaposi sarcoma therapy: new look at an old disease. Crit Rev Oncol Hematol. 2008 Dec;68(3):242-9. PubMed | Google Scholar

  2. Schwartz RA, Micali G, Nasca MR, Scuderi L. Kaposi sarcoma: a continuing conundrum. J Am Acad Dermatol. 2008 ;59(2):179-206. PubMed | Google Scholar

  3. Hbid O, Belloul L, Fajali N, Ismaili N, Duprez R, Tanguy M, Benomar H, Tahri EH, Gessain A, Huerre M. Kaposi's sarcoma in Morocco: a pathological study with immunostaining for human herpesvirus-8 LNA-1. Pathology. 2005 Aug;37(4):288-95. PubMed | Google Scholar

  4. Onunu AN, Okoduwa C, Eze EU, Adeyekun AA, Kubeyinje EP, Schwartz RA. Kaposi's sarcoma in Nigeria. Int J Dermatol. 2007;46 (3):264-7. PubMed | Google Scholar

  5. Serraino D, Angeletti C, Carrieri MP, Longo B, Piche M, Piselli P, et al. For the Immunosuppression and Cancer Study Group; Kaposi's sarcoma in transplant and HIVinfected patients: an epidemiologic study in Italy and France. Transplantation. 2005;80 (12):1699-704. PubMed | Google Scholar

  6. Jakob L, Metzler G, Chen KM, Garbe C. Non-AIDS associated Kaposi's sarcoma: clinical features and treatment outcome. PLoS One. 2011 Apr;6(4): e18397. PubMed | Google Scholar

  7. Martellotta F, Berretta M, Vaccher E, Schioppa O, Zanet E, Tirelli U. AIDS-related Kaposi's sarcoma: state of the art and therapeutic strategies. Curr HIV Res. 2009;7 (6):634-8. PubMed | Google Scholar

  8. Wyatt ME, Finlayson CJ, Moore-Gillon V. Kaposi's sarcoma masquerading as pyogenic granuloma of the nasal mucosa. J Laryngol Otol. 1998 Mar;112(3):280-2. PubMed | Google Scholar

  9. Ryan P, Aarons S, Murray D, Markham T, Oi'Sullivan S, Lyons F, Lee G, Fitzgibbon J. Human herpesvirus 8 (HHV-8) detected in two patients with Kaposi's sarcoma-like pyogenic granuloma. J Clin Pathol. 2002 Aug;55(8):619-22. PubMed | Google Scholar

  10. Cabibi D, Cacciatore M, Viviano E, Guarnotta C, Aragona F. 'Pyogenic granuloma-like Kaposi's sarcoma' on the hands: immunohistochemistry and human herpesvirus-8 detection. J Eur Acad Dermatol Venereol. 2009 May;23(5):587-9. PubMed | Google Scholar

  11. Balme B., Arbona E. Autres tumeurs vasculaires Dermatologie et infections sexuellement transmissibles : Publ Elsevier Musson (2009). 708-713.

  12. Grayson W, Pantanowitz L. Histological variants of cutaneous Kaposi sarcoma. Diagn Pathol. 2008 Jul 25;3:31. PubMed | Google Scholar

  13. Sangüeza OP, Requena L. Malignant neoplasms. Kaposi's sarcoma. In Pathologyof vascular skin lesions ; Clinicopathologic correlations Edited by: Sangüeza OP,Requena L. Humana Press, New Jersey; 2003:217-235.

  14. Grayson W. A re-appraisal of vascular proliferations in human immunodeficiency virus infected patients. S Afr Dermatol Rev. 2006;6:48 –57. PubMed | Google Scholar

  15. Grayson W. My approach to: The HIV-positive skin biopsy. J Clin Pathol. 2008; 61 (7):802-817. PubMed | Google Scholar

  16. Mesri EA, Cesarman E, Boshoff C. Kaposii's sarcoma and its associated herpesvirus. Nat Rev Cancer. 2010 Oct; 10(10):707-19. PubMed | Google Scholar

  17. Hbid O, Belloul L, Fajali N, Ismaili N, Duprez R, Tanguy M, et al. Kaposi's sarcoma in Morocco: a pathological study with immunostaining for human herpesvirus-8 LNA-1. Pathology. 2005 Aug; 37(4):288-95. PubMed | Google Scholar

  18. Cheuk W, Wong KO, Wong CS, Dinkel JE, Ben-Dor D, Chan JK. Immunostaining for human herpesvirus 8 latent nuclear antigen-1 helps distinguish Kaposi sarcoma from its mimickers. Am J Clin Pathol. 2004 Mar; 121(3):335-42. PubMed | Google Scholar